Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
mutant KRAS
Description:
Mutant KRAS is an altered form of the KRAS oncogene studied in cancer biology and targeted therapy.
Primary topic:
Protein Kinase Regulation and GTPase Signaling (24%)
Related topics:
Protein Kinase Regulation and GTPase Signaling (24%),
Pancreatic and Hepatic Oncology Research (14%)
OpenAlex ID:
keywords/mutant-kras
T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer
2016
·
Eric Tran
, Paul F. Robbins
, et al.
·
New England Journal of Medicine
·
1,443
PDF
Drug Resistance via Feedback Activation of Stat3 in Oncogene-Addicted Cancer Cells
2014
·
Ho-June Lee
, Guanglei Zhuang
, et al.
·
Cancer Cell
·
587
PDF
Proteomic Analysis of Exosomes from Mutant KRAS Colon Cancer Cells Identifies Intercellular Transfer of Mutant KRAS
2012
·
Michelle Demory Beckler
, James N. Higginbotham
, et al.
·
Molecular & Cellular Proteomics
·
565
The current understanding of KRAS protein structure and dynamics
2019
·
Tatu Pantsar
·
Computational and Structural Biotechnology Journal
·
333
PDF
Fatty Acid Oxidation Mediated by Acyl-CoA Synthetase Long Chain 3 Is Required for Mutant KRAS Lung Tumorigenesis
2016
·
Mahesh S. Padanad
, Georgia Konstantinidou
, et al.
·
Cell Reports
·
333
PDF
Impact of oncogenes in tumor angiogenesis: Mutant K- ras up-regulation of vascular endothelial growth factor/vascular permeability factor is necessary, but not sufficient for tumorigenicity of human colorectal carcinoma cells
1998
·
Futoshi Okada
, Janusz W. Rak
, et al.
·
Proceedings of the National Academy of Sciences
·
318
Farnesyltransferase inhibitors and cancer treatment: targeting simply Ras?
1997
·
Adrienne D Cox
, Channing J Der
·
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
·
318
Mutant KRas-Induced Mitochondrial Oxidative Stress in Acinar Cells Upregulates EGFR Signaling to Drive Formation of Pancreatic Precancerous Lesions
2016
·
Geou-Yarh Liou
, Heike Döppler
, et al.
·
Cell Reports
·
292
PDF
Metabolic networks in mutant KRAS-driven tumours: tissue specificities and the microenvironment
2021
·
Samuel A. Kerk
, Thales Papagiannakopoulos
, et al.
·
Nature reviews. Cancer
·
264
PDF
Preinvasive pancreatic neoplasia of ductal phenotype induced by acinar cell targeting of mutant Kras in transgenic mice.
2003
·
Paul J Grippo
, Patrick S Nowlin
, et al.
·
PubMed
·
241
Vaccination with mutant ras peptides and induction of T-cell responsiveness in pancreatic carcinoma patients carrying the corresponding RAS mutation
1995
·
M.K. Gjertsen
, J. Breivik
, et al.
·
The Lancet
·
225
PDF
Mutant KRAS Enhances Tumor Cell Fitness by Upregulating Stress Granules
2016
·
Elda Grabocka
, Dafna Bar-Sagi
·
Cell
·
224
PDF
Molecular Consequences of Silencing Mutant K-ras in Pancreatic Cancer Cells: Justification for K-ras–Directed Therapy
2005
·
Jason B. Fleming
, Guo-Liang Shen
, et al.
·
Molecular Cancer Research
·
223
In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance
2020
·
Chi Chun Wong
, Jiaying Xu
, et al.
·
Gastroenterology
·
197
Mutant KRAS Conversion of Conventional T Cells into Regulatory T Cells
2016
·
Stephanie Zdanov
, Magis Mandapathil
, et al.
·
Cancer Immunology Research
·
170
KRAS-Driven Metabolic Rewiring Reveals Novel Actionable Targets in Cancer
2019
·
Emanuela Pupo
, Daniele Avanzato
, et al.
·
Frontiers in Oncology
·
161
PDF
HDAC6 and SIRT2 Regulate the Acetylation State and Oncogenic Activity of Mutant K-RAS
2013
·
Moon Hee Yang
, Gaelle Laurent
, et al.
·
Molecular Cancer Research
·
154
Wild-Type H- and N-Ras Promote Mutant K-Ras-Driven Tumorigenesis by Modulating the DNA Damage Response
2014
·
Elda Grabocka
, Yuliya Pylayeva-Gupta
, et al.
·
Cancer Cell
·
153
PDF
Mutant K-Ras Activation of the Proapoptotic MST2 Pathway Is Antagonized by Wild-Type K-Ras
2011
·
David Matallanas
, David Romano
, et al.
·
Molecular Cell
·
151
A CRISPR-Cas13a system for efficient and specific therapeutic targeting of mutant KRAS for pancreatic cancer treatment
2018
·
Xiao Zhao
, Liang Liu
, et al.
·
Cancer Letters
·
143
GSK3 suppression upregulates β-catenin and c-Myc to abrogate KRas-dependent tumors
2018
·
Aslamuzzaman Kazi
, Shengyan Xiang
, et al.
·
Nature Communications
·
134
PDF
Oncogene cooperation in tumor maintenance and tumor recurrence in mouse mammary tumors induced by Myc and mutant Kras
2008
·
Katrina Podsypanina
, Katerina Politi
, et al.
·
Proceedings of the National Academy of Sciences
·
133
Targeting Mutant KRAS for Anticancer Therapeutics: A Review of Novel Small Molecule Modulators
2013
·
Yuanxiang Wang
, Christine E. Kaiser
, et al.
·
Journal of Medicinal Chemistry
·
131
Genome-Wide CRISPR Screen for Essential Cell Growth Mediators in Mutant KRAS Colorectal Cancers
2017
·
Edwin H. Yau
, Indrasena Reddy Kummetha
, et al.
·
Cancer Research
·
123
Biochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targeting
2021
·
Adham S. Bear
, Tatiana Blanchard
, et al.
·
Nature Communications
·
119
PDF
Show more works
View as search
Works count:
547
Citation count:
13,220
Year
Topic
Type